Income Statement MFS INTER INT NPV

Stocks

MIN

US55273C1071

Closed End Funds

Market Closed - NYSE 06:00:02 26/09/26 am AEST			5-day change	1st Jan Change
2.320 ^USD	+0.87%		-1.28%	-11.11%

11/09	Aberdeen Intermediate Income Fund announces Monthly dividend, payable on September 30, 2026	CI
11/08	Aberdeen Intermediate Income Fund announces Monthly dividend, payable on August 31, 2026	CI

698bd9b61d506.7ImW_CVI8SI29vjAo4XlL911xCg5nlB5KpWu2VDUOtE.nt7Xl39-xUtyo5mO8-S1TKoHinJV7mU2Y-fnnB6bc7uGztOSXwmwZE-irQ

Published financial data: MFS INTER INT NPV

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	-	-	-	-	-
Interest And Invest. Income (Rev)	11.94M	10.78M	11.56M	12.57M	12.3M
Total Revenues	11.94M	10.78M	11.56M	12.57M	12.3M
Gross Profit	11.94M	10.78M	11.56M	12.57M	12.3M
Selling General & Admin Expenses, Total	2.75M	2.49M	2.34M	2.33M	2.29M
Other Operating Expenses, Total	2.75M	2.49M	2.34M	2.33M	2.29M
Operating Income	9.19M	8.29M	9.22M	10.24M	10.01M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-140K	-1.2M	-3.55M	172K	587K
EBT, Excl. Unusual Items	9.05M	7.09M	5.66M	10.41M	10.6M
Gain (Loss) On Sale Of Investments	-6.89M	-50.97M	3.98M	16.9M	7.64M
EBT, Incl. Unusual Items	2.16M	-43.87M	9.65M	27.31M	18.24M
Earnings From Continuing Operations	2.16M	-43.87M	9.65M	27.31M	18.24M
Net Income to Company	2.16M	-43.87M	9.65M	27.31M	18.24M
Net Income - (IS)	2.16M	-43.87M	9.65M	27.31M	18.24M
Net Income to Common Incl Extra Items	2.16M	-43.87M	9.65M	27.31M	18.24M
Net Income to Common Excl. Extra Items	2.16M	-43.87M	9.65M	27.31M	18.24M
Per Share Items
Net EPS - Basic	0.02	-0.38	0.08	0.24	0.16
Basic EPS - Continuing Operations	0.02	-0.38	0.08	0.24	0.16
Basic Weighted Average Shares Outstanding	116M	115M	114M	114M	114M
Net EPS - Diluted	0.02	-0.38	0.08	0.24	0.16
Diluted EPS - Continuing Operations	0.02	-0.38	0.08	0.24	0.16
Diluted Weighted Average Shares Outstanding	116M	115M	114M	114M	114M
Normalized Basic EPS	0.05	0.04	0.03	0.06	0.06
Normalized Diluted EPS	0.05	0.04	0.03	0.06	0.06
Dividend Per Share	0.33	0.29	0.25	0.24	0.23
Supplemental Items
EBITA	9.19M	8.29M	9.22M	10.24M	10.01M
EBIT	9.19M	8.29M	9.22M	10.24M	10.01M
Total Revenues (As Reported)	11.94M	10.78M	11.56M	12.57M	12.3M
Normalized Net Income	5.66M	4.43M	3.54M	6.51M	6.63M
Non-Cash Pension Expense	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	2.75M	2.49M	2.34M	2.33M	2.29M

Fiscal Period: October	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	-	-	-	-	-
Total Cash And Short Term Investments	-	-	-	-	-
Accounts Receivable, Total	4.44M	2.53M	2.49M	2.59M	4.67M
Total Receivables	4.44M	2.53M	2.49M	2.59M	4.67M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	4.44M	2.53M	2.49M	2.59M	4.67M
Long-term Investments	420M	340M	323M	318M	308M
Other Long-Term Assets, Total	18.84K	18.91K	18.64K	18.47K	18.54K
Total Assets	424M	343M	325M	321M	313M
Liabilities
Accounts Payable, Total	1.5M	-	4.06M	872K	1.54M
Accrued Expenses, Total	197K	181K	153K	161K	163K
Other Current Liabilities	4.69K	142K	130K	167K	85.66K
Total Current Liabilities	1.7M	323K	4.34M	1.2M	1.78M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Other Non Current Liabilities	-	276	511K	-	-
Total Liabilities	1.7M	323K	4.85M	1.2M	1.78M
Common Stock, Total	411M	384M	363M	345M	328M
Retained Earnings	11.13M	-41.93M	-42.06M	-25.34M	-17.44M
Total Common Equity	422M	342M	321M	320M	311M
Total Equity	422M	342M	321M	320M	311M
Total Liabilities And Equity	424M	343M	325M	321M	313M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	116M	115M	114M	114M	114M
ECS Total Common Shares Outstanding	116M	115M	114M	114M	114M
Book Value / Share	3.64	2.98	2.81	2.81	2.73
Tangible Book Value	422M	342M	321M	320M	311M
Tangible Book Value Per Share	3.64	2.98	2.81	2.81	2.73
Total Debt	0	0	0	0	0
Net Debt	-	-	-	-	-
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3

Fiscal Period: October	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	1.3	1.35	1.72	1.98	1.98
Return on Total Capital	1.3	1.36	1.74	2	1.98
Return On Equity %	0.49	-11.47	2.91	8.53	5.78
Return on Common Equity	0.49	-11.47	2.91	8.53	5.78
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	23.03	23.11	20.26	18.56	18.61
EBITA Margin %	76.97	76.89	79.74	81.44	81.39
EBIT Margin %	76.97	76.89	79.74	81.44	81.39
Income From Continuing Operations Margin %	18.1	-406.95	83.46	217.22	148.24
Net Income Margin %	18.1	-406.95	83.46	217.22	148.24
Net Avail. For Common Margin %	18.1	-406.95	83.46	217.22	148.24
Normalized Net Income Margin	47.37	41.12	30.62	51.75	53.85
Asset Turnover
Asset Turnover	0.03	0.03	0.03	0.04	0.04
Receivables Turnover (Average Receivables)	-	-	-	-	-
Short Term Liquidity
Current Ratio	2.61	7.85	0.57	2.16	2.62
Quick Ratio	2.61	7.85	0.57	2.16	2.62
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Long Term Solvency
Total Liabilities / Total Assets	0.4	0.09	1.49	0.37	0.57
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-13.43	-9.7	7.22	8.78	-2.14
Gross Profit, 1 Yr. Growth %	-13.43	-9.7	7.22	8.78	-2.14
EBITA, 1 Yr. Growth %	-14.99	-9.8	11.2	11.09	-2.2
EBIT, 1 Yr. Growth %	-14.99	-9.8	11.2	11.09	-2.2
Earnings From Cont. Operations, 1 Yr. Growth %	-92.39	-2.13K	-121.99	183.12	-33.21
Net Income, 1 Yr. Growth %	-92.39	-2.13K	-121.99	183.12	-33.21
Normalized Net Income, 1 Yr. Growth %	-16.29	-21.62	-20.16	83.86	1.83
Diluted EPS Before Extra, 1 Yr. Growth %	-92.4	-2.15K	-122.16	183.65	-33.21
Accounts Receivable, 1 Yr. Growth %	33.69	-42.96	-1.85	3.95	80.57
Total Assets, 1 Yr. Growth %	-7.44	-19.21	-5.03	-1.39	-2.49
Tangible Book Value, 1 Yr. Growth %	-7.75	-18.96	-6.36	-0.28	-2.68
Common Equity, 1 Yr. Growth %	-7.75	-18.96	-6.36	-0.28	-2.68
Dividend Per Share, 1 Yr. Growth %	-4.02	-12.32	-11.58	-4.11	-5.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.67	-11.58	-1.6	8	3.17
Gross Profit, 2 Yr. CAGR %	-11.67	-11.58	-1.6	8	3.17
EBITA, 2 Yr. CAGR %	-13.25	-12.43	0.15	11.14	4.23
EBIT, 2 Yr. CAGR %	-13.25	-12.43	0.15	11.14	4.23
Earnings From Cont. Operations, 2 Yr. CAGR %	-77	24.27	111.28	-21.1	37.51
Net Income, 2 Yr. CAGR %	-77	24.27	111.28	-21.1	37.51
Normalized Net Income, 2 Yr. CAGR %	-13.92	-19	-20.9	21.15	36.83
Diluted EPS Before Extra, 2 Yr. CAGR %	-76.91	24.83	113.11	-20.72	37.64
Accounts Receivable, 2 Yr. CAGR %	-2.88	-12.68	-25.18	1	37
Total Assets, 2 Yr. CAGR %	-5.29	-13.53	-12.41	-3.23	-1.94
Tangible Book Value, 2 Yr. CAGR %	-5.44	-13.54	-12.89	-3.37	-1.49
Common Equity, 2 Yr. CAGR %	-5.44	-13.54	-12.89	-3.37	-1.49
Dividend Per Share, 2 Yr. CAGR %	-2.55	-8.27	-11.95	-7.92	-4.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.79	-11.02	-5.71	1.74	4.51
Gross Profit, 3 Yr. CAGR %	-6.79	-11.02	-5.71	1.74	4.51
EBITA, 3 Yr. CAGR %	-7.37	-12.12	-5.18	3.67	6.51
EBIT, 3 Yr. CAGR %	-7.37	-12.12	-5.18	3.67	6.51
Earnings From Cont. Operations, 3 Yr. CAGR %	-33.61	2.42	-30.23	132.93	-25.36
Net Income, 3 Yr. CAGR %	-33.61	2.42	-30.23	132.93	-25.36
Normalized Net Income, 3 Yr. CAGR %	-4.59	-16.57	-19.39	4.78	14.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-33.34	3.01	-29.84	134.42	-25.12
Accounts Receivable, 3 Yr. CAGR %	9.32	-18.67	-9.21	-16.51	22.59
Total Assets, 3 Yr. CAGR %	-3.71	-10.18	-10.78	-8.88	-2.98
Tangible Book Value, 3 Yr. CAGR %	-3.74	-10.18	-11.21	-8.87	-3.14
Common Equity, 3 Yr. CAGR %	-3.74	-10.18	-11.21	-8.87	-3.14
Dividend Per Share, 3 Yr. CAGR %	-3.39	-5.92	-9.38	-9.41	-6.98
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-6.03	-5.82	-4.75	-3.85	-2.25
Gross Profit, 5 Yr. CAGR %	-6.03	-5.82	-4.75	-3.85	-2.25
EBITA, 5 Yr. CAGR %	-6.06	-5.88	-4.43	-3.46	-1.52
EBIT, 5 Yr. CAGR %	-6.06	-5.88	-4.43	-3.46	-1.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-36.16	49.37	5.49	-7.73	-8.48
Net Income, 5 Yr. CAGR %	-36.16	49.37	5.49	-7.73	-8.48
Normalized Net Income, 5 Yr. CAGR %	-9.92	1.96	-11.48	-3.14	-0.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-35.97	50.1	6.11	-7.23	-8.14
Accounts Receivable, 5 Yr. CAGR %	2.47	-4.43	-6.06	-11.3	7.03
Total Assets, 5 Yr. CAGR %	-5.67	-8.29	-7.29	-7.46	-7.35
Tangible Book Value, 5 Yr. CAGR %	-5.66	-8.19	-7.51	-7.52	-7.44
Common Equity, 5 Yr. CAGR %	-5.66	-8.19	-7.51	-7.52	-7.44
Dividend Per Share, 5 Yr. CAGR %	-4.95	-6.17	-6.91	-6.73	-7.5

Fiscal Period: October	2016 (USD)	2017 (USD)	2018 (USD)	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Supplemental Items
Change In Net Working Capital						-254K	-530K	-4.06M	3.24M	1.5M